Table 5.
Intra-class correlation coefficient of HM-PRO across different hematological malignancies.
| Disease Diagnosis | Part A Domains | Scales | ||||
|---|---|---|---|---|---|---|
| Physical Behavior | Social Well-being | Emotional Behavior | Eating and Drinking | Part A | Part B | |
| ALL | 0.96 | 0.80 | 0.89 | 0.53 | 0.94 | 0.87 |
| MPN | 0.88 | 0.85 | 0.92 | 0.87 | 0.95 | 0.91 |
| AML | 0.77 | 0.85 | 0.85 | 0.81 | 0.81 | 0.84 |
| ANHL | 0.94 | 0.98 | 0.97 | 0.45 | 0.97 | 0.92 |
| CLL | 0.99 | 0.87 | 0.95 | 0.82 | 0.97 | 0.94 |
| CML | 0.74 | 0.83 | 0.83 | 0.93 | 0.82 | 0.91 |
| HL | 0.89 | 0.79 | 0.87 | 0.81 | 0.86 | 0.94 |
| INHL | 0.93 | 0.89 | 0.92 | 0.95 | 0.92 | 0.93 |
| MDS | 0.94 | 0.86 | 0.83 | 0.95 | 0.91 | 0.70 |
| MM | 0.94 | 0.71 | 0.86 | 0.93 | 0.93 | 0.95 |
ALL, acute lymphoid leukemia; AML, acute myeloid leukemia; CLL, chronic lymphoid leukaemia; CML, chronic myeloid leukemia; MM, multiple myeloma; INHL, indolent non-Hodgkin lymphoma; ANHL, aggressive non-Hodgkin lymphoma; HL, Hodgkin lymphoma; MDS, myelodysplastic syndrome; MPN, myeloproliferative neoplasm.